Values for preventing influenza-related morbidity and vaccine adverse events in children

BACKGROUND: Influenza vaccination recently has been recommended for children 6–23 months old, but is not currently recommended for routine use in non-high-risk older children. Information on disease impact, costs, benefits, risks, and community preferences could help guide decisions about which age...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosser, Lisa A, Bridges, Carolyn Buxton, Uyeki, Timothy M, Rêgo, Virginia H, Ray, G Thomas, Meltzer, Martin I, Schwartz, Benjamin, Thompson, William W, Fukuda, Keiji, Lieu, Tracy A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083419/
https://www.ncbi.nlm.nih.gov/pubmed/15780143
http://dx.doi.org/10.1186/1477-7525-3-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1083419/
https://www.ncbi.nlm.nih.gov/pubmed/15780143
http://dx.doi.org/10.1186/1477-7525-3-18

Ejemplares similares